Warren Cresswell Appointed CEO of Perspectum by Slone Partners

Warren Cresswell Takes the Helm at Perspectum

In a significant move for the precision healthcare sector, Warren Cresswell has been appointed Chief Executive Officer (CEO) of Perspectum, a pioneering firm focused on delivering non-invasive solutions for drug development and improving patient outcomes in liver and cardiometabolic diseases. This announcement comes courtesy of Slone Partners, a nationwide executive search firm specializing in the life sciences and healthcare industries.

A Leader with Extensive Experience

Warren's impressive career spans over 25 years, where he has amassed a wealth of experience across various domains, including diagnostics, pharmaceuticals, medical devices, and laboratory services. Prior to his new role at Perspectum, he served as President and CEO of Prometheus Laboratories, a subsidiary of Nestlé Health Science. During his tenure there, he successfully led the diagnostics business through an era of considerable growth, establishing commercial and CLIA-certified laboratory infrastructures for FDA-approved diagnostics throughout the United States. More recently, he has advocated for advancements in precision oncology technology.

Leslie Loveless, the CEO and Managing Partner at Slone Partners, expressed her enthusiasm about Warren's appointment, stating, "Warren brings an exceptional combination of global leadership experience, commercial expertise, and deep knowledge across diagnostics and precision health. His proven ability to build and scale organizations will be tremendously valuable as Perspectum advances its innovative technologies and expands its impact on drug development and patient care."

Bridging Science and Business

The search for a new CEO was thoroughly led by Sona Stroud, Senior Partner at Slone Partners, who also highlighted Warren’s unique qualifications that make him an ideal fit for Perspectum at this pivotal moment. "His unique combination of scientific and technology expertise, along with his operational leadership skills, positions him well to translate innovation into meaningful impacts both clinically and in business," she said. Stroud also emphasized the rewarding nature of this search process, praising both Perspectum’s distinguished board and Warren’s leadership qualities.

Dr. Michael Rosenblatt, Chairperson of Perspectum, also shared his thoughts on the new appointment, stating, "I am thrilled with the selection of Warren Cresswell as our next CEO. He embodies the leadership talent and experience that are vital for this company during its growth and development phase. We are eager to have him at the helm."

Educational Background

Warren Cresswell possesses a BA in Chemistry from California State University and an MBA from the University of Pittsburgh. His academic foundation complements his extensive industry experience, blending scientific understanding with business acumen.

About Slone Partners

Slone Partners has carved out a reputation as a premier executive search firm with over 25 years of success. The firm specializes in the life sciences and healthcare industries, focusing on discovering and placing innovative leaders in roles including Board, C-Suite, and upper management positions. With a nationwide presence and global reach, Slone Partners prides itself on delivering visionary leaders and fractional talent to help organizations grow and thrive.

To learn more about Slone Partners and its array of success stories, visit Slone Partners' website or call 888.784.3422.

About Perspectum

Perspectum is a global medical technology company dedicated to developing advanced imaging solutions that facilitate earlier diagnosis and more personalized care for patients suffering from cardiometabolic conditions. With operations across the UK, EU, Asia, and the USA, Perspectum binds together biomedical science, clinical expertise, and quantitative imaging analytics to support clinicians in making informed decisions for patient care. For further details, explore Perspectum's official site.